Nishi Shah

18PUBLICATIONS
98CO-AUTHORS
Respiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jan 06, 2026
Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study.

Lemchukwu Amaeshi, Lauren Laufer, Kateryna Fedorov

|Aug 21, 2025
Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratification.

Rajvi Gor, Jeevan Shivakumar, Pallavi Surana

|Jul 25, 2025
CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected Cases.

Nishi Shah, Melissa Suchanek, Astha Thakkar

|Apr 25, 2025
A phase 2 randomized study of modakafusp alfa as a single agent for patients with relapsed/refractory multiple myeloma.

Sarah A Holstein, Shebli Atrash, Hira Mian

|Apr 23, 2025
Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma.

Meera Mohan, Aniko Szabo, Heloise Cheruvalath

|Feb 07, 2025
Venetoclax plus daunorubicin and cytarabine for newly diagnosed acute myeloid leukemia: results of a phase 1b study.

Ioannis Mantzaris, Mendel Goldfinger, Matan Uriel

Pageof 3

Frequent Collaborators

6 joint publications

Meera Mohan

6 joint publications

Kira Gritsman

6 joint publications

Aditi Shastri

5 joint publications

Carolina Schinke